Atlas Trials

Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone

Clinical trial NCT02733679 · COMPLETED

Trial details

NCT number
NCT02733679
Sponsor
NHS Tayside
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ataxia-Telangiectasia
Start date
2016-09-29
Primary completion
2017-08-30
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.